ADIPEX-VR 75mg/tab 30 Tablets by Vital Research

Usage

1. Establish your personal baseline: record resting heart rate and blood pressure on the morning before day one — this is your reference point for evaluating dose response at every titration step.
2. Start the ramp-up at half a tablet (37.5 mg) taken in the morning on an empty stomach; use ADIPEX-VR's score line to split cleanly and store the remaining half in the blister until the next dose.
3. After seven days at 37.5 mg, reassess HR and BP; if both remain within acceptable personal limits (HR < 85 bpm resting, systolic BP rise < 10 mmHg above your baseline), advance to the full 75 mg tablet.
4. Maintain the 75 mg plateau dose through weeks 3–6; do not increase beyond one tablet per day — 75 mg represents the published clinical ceiling for Phentermine.
5. Begin the taper no later than one week before your intended last day: return to the half-tablet (37.5 mg) for three to four days, then every-other-day dosing for a further three to four days before stopping completely.
6. After full cessation, allow a minimum four-week washout before considering a repeat cycle; use this window to reassess diet adherence and cardiovascular markers before planning any further stimulant use.

Warnings

Frequently asked questions

How do you step up the Phentermine dose week by week without overloading your system?

Start at half a tablet (37.5 mg) for days 1–7 to let your cardiovascular and CNS baseline adjust. If resting heart rate and blood pressure remain within your personal acceptable range after seven days, advance to one full 75 mg tablet from week two onward. Never increase by more than one half-tablet increment per week; faster escalation increases the likelihood of side effects without proportional benefit.

Why is a slow taper necessary at the end of a Phentermine cycle?

Phentermine promotes sustained norepinephrine release; abrupt removal leaves the CNS temporarily under-stimulated, which can trigger rebound appetite and energy slump. A step-down taper — reducing by 37.5 mg every three to four days over one to two weeks — gives central adrenergic receptors time to return to baseline sensitivity progressively rather than all at once.

How do I know I have reached the maximum daily dose and should not go higher?

The clinical ceiling for Phentermine is 75 mg/day per standard prescribing references. Practically, signs that you are at your individual maximum include persistent resting heart rate elevation above 90 bpm, difficulty sleeping despite morning dosing, or notable anxiety. If any of these appear at the full 75 mg dose, step back to 37.5 mg rather than attempting to exceed the labelled ceiling.

What makes the 75 mg per tablet concentration an advantage for titration compared to lower-strength options?

At 75 mg per tablet, ADIPEX-VR covers the full clinically approved daily dose in a single unit, while a scored tablet allows a clean 37.5 mg half-dose for ramp-up and taper phases. Lower-strength tablets (e.g., 37.5 mg) require two tablets to reach the same ceiling, adding dosing steps. The 75 mg format gives two functional dose points from one blister without needing a second product.

Can ADIPEX-VR tablets be split cleanly for the half-dose titration phases?

Yes — ADIPEX-VR tablets are produced with a score line specifically to facilitate equal splitting. HPLC content uniformity testing on the Vital Research manufacturing line confirms that active Phentermine content is evenly distributed across the tablet matrix, meaning a physical half produces a dose reliably close to 37.5 mg rather than an unpredictable fragment. (2) angle_used

Manufacturer

Vital Research's approach to compound specialisation is most visible at the concentration level: rather than offering every active ingredient at a single mid-range dose, the brand selects tablet strengths that map directly onto the clinical or research dose range associated with each specific compound. For Phentermine, that decision results in a 75 mg tablet — the upper boundary of the accepted daily prescription dose — rather than a conservative intermediate. Reaching consistent 75 mg delivery across all 30 tablets in a blister demands tighter content-uniformity controls than lower-concentration formats permit; Vital Research addresses this through lot-specific HPLC quantification against a reference standard and LAL endotoxin screening, with results documented on a per-SKU certificate of analysis traceable to the individual lot code printed on each blister unit.